NASDAQ:OPGN
OpGen, Inc. Stock News
$0.535
+0.0201 (+3.90%)
At Close: Apr 29, 2024
Curetis N.V. : in liquidatie to announce liquidation distribution in advance and last trading day | MarketScreener
05:59am, Monday, 20'th Apr 2020INO, BBBY among premarket gainers
01:19pm, Thursday, 16'th Apr 2020
Edison Nation (NASDAQ:EDNT) +169% on over $10M order.Soligenix (NASDAQ:SNGX) +91% on deal for COVID-19 vaccine adjuvant.Atossa Therapeutics (NASDAQ:ATOS) +82% on launching COVID-19 HOPE drug devel
Peer-reviewed study evaluated performance of AI-powered bioinformatics cloud platform, ares-genetics.cloud, for NGS-based antibiotic susceptibility testing on 12 pathogenic.
OpGen Announces Preliminary Unaudited Revenue and Cash Position for First Quarter 2020 and Provides Business Update
11:30am, Tuesday, 14'th Apr 2020
OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that total revenu
Edited Transcript of OPGN earnings conference call or presentation 24-Mar-20 8:30pm GMT
05:17am, Sunday, 05'th Apr 2020
Q4 2019 OpGen Inc Earnings Call
Here's a roundup of top developments in the biotech space over the last 24 hours.On a day when the three major averages shed over 4% in reaction to bleak forecasts concerning the COVID-19 pandemic's
Curetis N : and OpGen Close Business Combination | MarketScreener
09:47pm, Wednesday, 01'st Apr 2020Curetis and OpGen Close Business Combination | MarketScreener
09:42pm, Wednesday, 01'st Apr 2020OpGen and Curetis Successfully Close their Business Combination Transaction
08:00pm, Wednesday, 01'st Apr 2020
OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that the business
OpGen Announces Shareholder Approval for Business Combination with Curetis
02:50pm, Monday, 30'th Mar 2020
OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that, following i
Curetis N : OpGen Announces Shareholder Approval for Business Combination with Curetis | MarketScreener
02:50pm, Monday, 30'th Mar 2020Curetis N.V. : Informs on OpGen's Fourth Quarter and Full Year 2019 Financial Results and Business Update | MarketScreener
05:59am, Wednesday, 25'th Mar 20205 Stocks Moving In Tuesday's After-Hours Session
08:50pm, Tuesday, 24'th Mar 2020
AAR (NYSE: AIR) shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.
Nike (NYSE: NKE) shares are trading higher after the...
OpGen Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update for OpGen and Curetis Group
08:05pm, Tuesday, 24'th Mar 2020
Quorum achieved for OpGen stockholder vote on Curetis business combination with 99% of votes supporting transactionTransaction close anticipated by early April 2020Combined.
OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis
01:00pm, Tuesday, 24'th Mar 2020
OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today an update on shar
